Johannes Ring Selected Research

Melanoma (Melanoma, Malignant)

8/2003	Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis.
4/2002	Endocrinologic changes in male patients with melanoma during interferon alfa-2b therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes Ring Research Topics

Disease

50	Atopic Dermatitis (Atopic Eczema) 05/2024 - 01/2002
50	Hypersensitivity (Allergy) 10/2023 - 01/2002
33	Anaphylaxis (Anaphylactic Shock) 12/2023 - 01/2002
15	Asthma (Bronchial Asthma) 01/2021 - 01/2006
12	Inflammation (Inflammations) 01/2021 - 06/2002
12	Eczema 10/2016 - 01/2002
8	Skin Diseases (Skin Disease) 01/2021 - 11/2002
7	COVID-19 08/2021 - 01/2020
7	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2016 - 11/2002
7	Infections 11/2012 - 01/2004
6	Seasonal Allergic Rhinitis (Hay Fever) 01/2018 - 04/2003
5	Urticaria (Hives) 02/2024 - 02/2002
5	Allergic Rhinitis 01/2021 - 01/2003
5	Neoplasms (Cancer) 11/2013 - 02/2005
4	Contact Dermatitis (Eczema, Contact) 07/2014 - 01/2008
4	Pruritus (Itching) 03/2013 - 02/2006
4	Hypereosinophilic Syndrome (Loeffler Endocarditis) 02/2013 - 03/2008
3	Bites and Stings (Sting) 10/2023 - 01/2014
3	Chronic Urticaria 01/2021 - 01/2013
3	Allergic Contact Dermatitis 01/2021 - 04/2007
3	Pain (Aches) 10/2018 - 03/2003
3	Angioedema 04/2012 - 02/2002
3	Fabry Disease (Fabry's Disease) 02/2010 - 01/2003
2	Bullous Pemphigoid (Pemphigoid) 01/2021 - 07/2012
2	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 03/2008
2	Pemphigus (Pemphigus Vulgaris) 01/2021 - 07/2012
2	Disease Progression 01/2020 - 03/2013
2	Shock 01/2018 - 01/2010
2	Venom Hypersensitivity 05/2015 - 04/2006
2	Superinfection 03/2013 - 01/2002
2	Alopecia (Baldness) 03/2010 - 01/2005
2	Candidiasis (Moniliasis) 11/2008 - 12/2007
2	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 06/2008 - 07/2006
2	Melanoma (Melanoma, Malignant) 08/2003 - 04/2002
1	Overweight 12/2023
1	Severe Acute Respiratory Syndrome 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021

Drug/Important Bio-Agent (IBA)

37	Immunoglobulin E (IgE)IBA 12/2023 - 01/2002
37	AllergensIBA 10/2023 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
8	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 01/2010
8	AntibodiesIBA 12/2023 - 04/2003
7	Arthropod VenomsIBA 10/2023 - 01/2004
7	VaccinesIBA 01/2021 - 06/2011
7	CytokinesIBA 07/2014 - 06/2002
6	AntigensIBA 01/2021 - 01/2007
6	Tryptases (Tryptase)IBA 08/2014 - 01/2003
6	NickelIBA 01/2014 - 06/2004
6	Filaggrin ProteinsIBA 01/2012 - 07/2006
5	pimecrolimus (Elidel)FDA Link 06/2015 - 01/2006
4	AutoantibodiesIBA 12/2023 - 01/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2015 - 03/2008
4	Histamine (Histamine Dihydrochloride)FDA Link 01/2014 - 01/2010
4	Interleukin-17 (Interleukin 17)IBA 11/2012 - 11/2008
4	LipidsIBA 01/2012 - 05/2002
3	Local Anti-Infective Agents (Antiseptics)IBA 09/2013 - 04/2010
3	mepolizumabIBA 02/2013 - 03/2008
3	VenomsIBA 08/2012 - 04/2006
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2010 - 01/2002
2	Peptides (Polypeptides)IBA 12/2023 - 01/2018
2	Wasp Venoms (Venom, Wasp)IBA 10/2023 - 01/2014
2	Budesonide (Pulmicort)FDA LinkGeneric 08/2021 - 01/2021
2	COVID-19 VaccinesIBA 01/2021 - 01/2021
2	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2021 - 01/2014
2	BNT162 VaccineIBA 01/2021 - 01/2021
2	Monoclonal AntibodiesIBA 01/2020 - 03/2008
2	Immunoglobulin G (IgG)IBA 01/2018 - 01/2004
2	SilverIBA 10/2017 - 01/2003
2	EnzymesIBA 10/2017 - 02/2010
2	Omalizumab (Xolair)FDA Link 01/2016 - 05/2008
2	SteroidsIBA 08/2014 - 01/2002
2	Eosinophil Cationic ProteinIBA 08/2014 - 01/2003
2	Interleukin-10 (Interleukin 10)IBA 07/2014 - 12/2007
2	Histamine Antagonists (Antihistamines)IBA 04/2014 - 03/2013
2	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 08/2011
2	Calcineurin InhibitorsIBA 11/2013 - 01/2008
2	Contrast MediaIBA 08/2011 - 01/2010
2	Interleukin-22 (IL-22)IBA 07/2011 - 11/2008
2	anti-IgE antibodiesIBA 05/2011 - 11/2007
2	Peptide Hydrolases (Proteases)FDA Link 01/2008 - 05/2006
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2008 - 01/2002
2	Ointments (Pastes)IBA 01/2008 - 01/2002
2	APTIBA 01/2006 - 07/2004
2	Interleukin-2 (IL2)IBA 08/2003 - 06/2002
2	Interferon alpha-2 (Roferon-A)FDA Link 08/2003 - 04/2002
1	Ranitidine (Zantac)FDA LinkGeneric 02/2024
1	Diphenhydramine (Benadryl)FDA LinkGeneric 02/2024
1	Cimetidine (Biomet)FDA LinkGeneric 02/2024
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	nickel sulfate FDA Link 01/2021

Therapy/Procedure

42	Therapeutics 05/2024 - 01/2002
12	Immunotherapy 05/2024 - 01/2003
3	Injections 01/2018 - 01/2003
2	Complementary Therapies (Alternative Medicine) 05/2024 - 12/2003
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2014
2	Radiotherapy 10/2018 - 09/2012
2	Acupuncture Therapy 07/2014 - 04/2011
2	Lasers (Laser) 08/2009 - 01/2003
2	Enzyme Replacement Therapy 07/2007 - 01/2003
1	Emergency Treatment 01/2021